219 related articles for article (PubMed ID: 34409540)
1. Meibomian gland atrophy with duration of Sjogren's syndrome in adult females.
Noh SR; Chung JL; Lee JM; Seo KY; Koh K
Int Ophthalmol; 2022 Jan; 42(1):191-200. PubMed ID: 34409540
[TBL] [Abstract][Full Text] [Related]
2. Does Sjogren's syndrome affect only the lacrimal gland in the eye? Time to replace the missing stones.
Gurlevik U; Karakoyun A; Yasar E
Indian J Ophthalmol; 2021 Jan; 69(1):53-57. PubMed ID: 33323573
[TBL] [Abstract][Full Text] [Related]
3. Meibomian gland dropout in Sjögren's syndrome and non-Sjögren's dry eye patients.
Zang S; Cui Y; Cui Y; Fei W
Eye (Lond); 2018 Nov; 32(11):1681-1687. PubMed ID: 29934634
[TBL] [Abstract][Full Text] [Related]
4. Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren's syndrome patients and nondry eye controls.
Menzies KL; Srinivasan S; Prokopich CL; Jones L
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):836-41. PubMed ID: 25574045
[TBL] [Abstract][Full Text] [Related]
5. Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.
Kang YS; Lee HS; Li Y; Choi W; Yoon KC
Int Ophthalmol; 2018 Jun; 38(3):1161-1167. PubMed ID: 28567496
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the first tear film break-up point in Sjögren's syndrome and non-Sjögren's syndrome dry eye patients.
Zhao S; Le Q
BMC Ophthalmol; 2022 Jan; 22(1):1. PubMed ID: 34980014
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Meibomian Gland Imaging Findings and Lipid Layer Thickness between Primary Sjögren Syndrome and Non-Sjögren Syndrome Dry Eyes.
Hwang JH; Lee JH; Chung SH
Ocul Immunol Inflamm; 2020; 28(2):182-187. PubMed ID: 30794472
[No Abstract] [Full Text] [Related]
8. [Clinical characteristics of patients with dry eye syndrome].
Zhang M; Chen JQ; Liu ZG; Lou LH; Xiao QG; Yao Y; Chen LS; Zhang ZH
Zhonghua Yan Ke Za Zhi; 2003 Jan; 39(1):5-9. PubMed ID: 12760805
[TBL] [Abstract][Full Text] [Related]
9. Meibomian gland dysfunction in patients with Sjögren syndrome.
Shimazaki J; Goto E; Ono M; Shimmura S; Tsubota K
Ophthalmology; 1998 Aug; 105(8):1485-8. PubMed ID: 9709762
[TBL] [Abstract][Full Text] [Related]
10. Tear Lysozyme in Sjögren´s syndrome, Meibomian gland dysfunction, and non-dry-eye.
Berra M; Galperín G; Berra F; Marquez MI; Mandaradoni M; Tau J; Berra A
Arq Bras Oftalmol; 2021; 85(2):103-108. PubMed ID: 34431892
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of ocular surface status and function in primary Sjögren's syndrome with hypothyroidism].
Yu HZ; Zeng WZ; Wu WY; Yao ZQ; Feng Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):705-711. PubMed ID: 35950396
[TBL] [Abstract][Full Text] [Related]
12. Tear lipid layer thickness and ocular comfort with a novel device in dry eye patients with and without Sjögren's syndrome.
Spiteri A; Mitra M; Menon G; Casini A; Adams D; Ricketts C; Hickling P; Fuller ET; Fuller JR
J Fr Ophtalmol; 2007 Apr; 30(4):357-64. PubMed ID: 17486027
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with ocular surface epithelial damage in patients with primary Sjögren's syndrome.
Kim JE; Kim NR; Chin HS; Seo KY; Kim TI; Jung JW
BMC Ophthalmol; 2021 Mar; 21(1):114. PubMed ID: 33653304
[TBL] [Abstract][Full Text] [Related]
14. Structural and Functional Evaluation of Meibomian Glands and Its Correlation With Dry Eye Parameters in Stevens-Johnson Syndrome.
Panjiyar M; Sadhu S; Shobha PS; S S; Agarwal S; Srinivasan B; Iyer G
Am J Ophthalmol; 2022 Aug; 240():187-193. PubMed ID: 35288074
[TBL] [Abstract][Full Text] [Related]
15. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.
Vitali C; Moutsopoulos HM; Bombardieri S
Ann Rheum Dis; 1994 Oct; 53(10):637-47. PubMed ID: 7979575
[TBL] [Abstract][Full Text] [Related]
16. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
Ozek D; Kemer OE; Omma A
Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
[TBL] [Abstract][Full Text] [Related]
17. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
[TBL] [Abstract][Full Text] [Related]
18. Oral and ocular manifestations in Sjögren's syndrome.
Kalk WW; Mansour K; Vissink A; Spijkervet FK; Bootsma H; Kallenberg CG; Roodenburg JL; Nieuw Amerongen AV
J Rheumatol; 2002 May; 29(5):924-30. PubMed ID: 12022351
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's Syndrome, Non-Sjögren's Syndrome, and Graft-Versus-Host Disease Related Dry Eye.
Ogawa Y
Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES71-DES79. PubMed ID: 30481809
[TBL] [Abstract][Full Text] [Related]
20. Meibomian Gland Dysfunction in Primary and Secondary Sjögren Syndrome.
Sullivan DA; Dana R; Sullivan RM; Krenzer KL; Sahin A; Arica B; Liu Y; Kam WR; Papas AS; Cermak JM
Ophthalmic Res; 2018; 59(4):193-205. PubMed ID: 29627826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
